• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌和牛分枝杆菌对异烟肼耐药的分子机制

Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis.

作者信息

Rouse D A, Morris S L

机构信息

Laboratory of Mycobacteria, Food and Drug Administration, Bethesda, Maryland 20892.

出版信息

Infect Immun. 1995 Apr;63(4):1427-33. doi: 10.1128/iai.63.4.1427-1433.1995.

DOI:10.1128/iai.63.4.1427-1433.1995
PMID:7890405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC173170/
Abstract

Genetic and biochemical studies have suggested a link between reduced catalase activity and resistance to isoniazid in Mycobacterium tuberculosis. In this study, we examined the molecular mechanisms of resistance to isoniazid with six in vitro mutants of the M. tuberculosis complex (Mycobacterium bovis and M. tuberculosis). Five of six mutants resistant to isoniazid were negative by catalase assays. Immunoblot analyses using a polyclonal antibody against the katG gene product (catalase-peroxidase) demonstrated that the enzyme is not produced in four of these isoniazid-resistant strains. A complete deletion of the katG gene was detected in only one of these isoniazid-resistant M. tuberculosis complex strains by Southern blot analyses. In two other resistant strains, partial deletions of the katG gene were identified. A point mutation which resulted in the insertion of a termination codon in the katG coding sequence caused a catalase-negative phenotype in a fourth strain. Of the two resistant strains which produce the enzyme, one was shown to be negative by a catalase assay. Single-stranded conformational polymorphism and DNA sequence analyses identified a mutation in the katG gene of this strain which may contribute to reduced enzymatic activity and subsequent isoniazid resistance. These data demonstrate that genetic alterations to the katG gene other than complete deletions are prevalent and may contribute significantly to the number of cases of isoniazid-resistant tuberculosis.

摘要

遗传学和生物化学研究表明,结核分枝杆菌中过氧化氢酶活性降低与对异烟肼的耐药性之间存在联系。在本研究中,我们用结核分枝杆菌复合群(牛分枝杆菌和结核分枝杆菌)的六个体外突变株研究了对异烟肼耐药的分子机制。六个异烟肼耐药突变株中有五个过氧化氢酶检测呈阴性。使用针对katG基因产物(过氧化氢酶-过氧化物酶)的多克隆抗体进行的免疫印迹分析表明,在这些异烟肼耐药菌株中有四个未产生该酶。通过Southern印迹分析,在这些异烟肼耐药的结核分枝杆菌复合群菌株中仅检测到一株katG基因完全缺失。在另外两株耐药菌株中,鉴定出katG基因部分缺失。在第四株菌株中,一个导致katG编码序列中插入终止密码子的点突变导致了过氧化氢酶阴性表型。在两株产生该酶的耐药菌株中,一株过氧化氢酶检测呈阴性。单链构象多态性和DNA序列分析确定该菌株的katG基因存在突变,这可能导致酶活性降低并随后产生异烟肼耐药性。这些数据表明,除了完全缺失外,katG基因的遗传改变很普遍,可能在很大程度上导致了异烟肼耐药结核病的病例数。

相似文献

1
Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis.结核分枝杆菌和牛分枝杆菌对异烟肼耐药的分子机制
Infect Immun. 1995 Apr;63(4):1427-33. doi: 10.1128/iai.63.4.1427-1433.1995.
2
Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.通过自动DNA测序对结核分枝杆菌异烟肼耐药和敏感菌株中过氧化氢酶-过氧化物酶基因(katG)和inhA基因座的特征分析:与耐药相关的有限突变阵列
J Infect Dis. 1996 Jan;173(1):196-202. doi: 10.1093/infdis/173.1.196.
3
Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis.过氧化氢酶-过氧化物酶基因(katG)中的错义突变与结核分枝杆菌对异烟肼的耐药性有关。
Mol Microbiol. 1995 Jan;15(2):235-45. doi: 10.1111/j.1365-2958.1995.tb02238.x.
4
Mutations in the catalase-peroxidase gene from isoniazid-resistant Mycobacterium tuberculosis isolates.来自耐异烟肼结核分枝杆菌分离株的过氧化氢酶-过氧化物酶基因突变。
J Infect Dis. 1994 May;169(5):1162-5. doi: 10.1093/infdis/169.5.1162.
5
Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance.结核分枝杆菌katG基因的定点诱变:对过氧化氢酶-过氧化物酶活性及异烟肼耐药性的影响
Mol Microbiol. 1996 Nov;22(3):583-92. doi: 10.1046/j.1365-2958.1996.00133.x.
6
Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.结核分枝杆菌中异烟肼耐药相关的过氧化氢酶-过氧化物酶(KatG)临床突变体与异烟肼衍生物相互作用分析。
J Glob Antimicrob Resist. 2017 Dec;11:57-67. doi: 10.1016/j.jgar.2017.06.014. Epub 2017 Jul 23.
7
Catalase expression, katG, and MIC of isoniazid for Mycobacterium tuberculosis isolates from São Paulo, Brazil.巴西圣保罗结核分枝杆菌分离株的过氧化氢酶表达、katG基因及异烟肼最低抑菌浓度
J Infect Dis. 1995 Jan;171(1):237-40. doi: 10.1093/infdis/171.1.237.
8
Identification and analysis of mutations in the katG gene in multidrug-resistant Mycobacterium tuberculosis clinical isolates.耐多药结核分枝杆菌临床分离株中katG基因突变的鉴定与分析
Pneumonol Alergol Pol. 2013;81(4):298-307.
9
Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.结核分枝杆菌异烟肼耐药临床分离株katG和inhA基因的特征分析
Antimicrob Agents Chemother. 1995 Nov;39(11):2472-7. doi: 10.1128/AAC.39.11.2472.
10
Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City.来自纽约市的结核分枝杆菌异烟肼敏感株和耐药株中的过氧化氢酶-过氧化物酶基因序列。
J Infect Dis. 1993 Oct;168(4):1063-5. doi: 10.1093/infdis/168.4.1063.

引用本文的文献

1
Homo-BacPROTAC-induced degradation of ClpC1 as a strategy against drug-resistant mycobacteria.利用 Homo-BacPROTAC 诱导 ClpC1 降解作为抗耐药分枝杆菌的策略。
Nat Commun. 2024 Mar 5;15(1):2005. doi: 10.1038/s41467-024-46218-7.
2
Heterologous production of the D-cycloserine intermediate O-acetyl-L-serine in a human type II pulmonary cell model.在人Ⅱ型肺细胞模型中 D-环丝氨酸中间产物 O-乙酰-L-丝氨酸的异源生产。
Sci Rep. 2023 May 26;13(1):8551. doi: 10.1038/s41598-023-35632-4.
3
Anti-tubercular derivatives of rhein require activation by the monoglyceride lipase Rv0183.大黄酸的抗结核衍生物需要由单甘油酯脂肪酶Rv0183激活。
Cell Surf. 2020 Apr 21;6:100040. doi: 10.1016/j.tcsw.2020.100040. eCollection 2020 Dec.
4
Reference set of Mycobacterium tuberculosis clinical strains: A tool for research and product development.结核分枝杆菌临床分离株参考集:研究和产品开发的工具。
PLoS One. 2019 Mar 25;14(3):e0214088. doi: 10.1371/journal.pone.0214088. eCollection 2019.
5
Catalase Inhibits the Formation of Mast Cell Extracellular Traps.过氧化氢酶抑制肥大细胞细胞外陷阱的形成。
Front Immunol. 2018 May 28;9:1161. doi: 10.3389/fimmu.2018.01161. eCollection 2018.
6
Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target.分枝杆菌细胞壁生物合成:一个多层面的抗生素靶点。
Parasitology. 2018 Feb;145(2):116-133. doi: 10.1017/S0031182016002377. Epub 2016 Dec 15.
7
Consequences of genomic diversity in Mycobacterium tuberculosis.结核分枝杆菌基因组多样性的后果。
Semin Immunol. 2014 Dec;26(6):431-44. doi: 10.1016/j.smim.2014.09.012. Epub 2014 Oct 22.
8
Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing.采用单一多重 PCR 和 DNA 测序快速鉴定分枝杆菌和耐药结核分枝杆菌。
J Clin Microbiol. 2012 Feb;50(2):326-36. doi: 10.1128/JCM.05570-11. Epub 2011 Dec 7.
9
Structure of Mycobacterium tuberculosis thioredoxin in complex with quinol inhibitor PMX464.结核分枝杆菌硫氧还蛋白与喹诺酮抑制剂 PMX464 的复合物结构。
Protein Sci. 2011 Jan;20(1):210-5. doi: 10.1002/pro.533.
10
Exploring the structure and function of the mycobacterial KatG protein using trans-dominant mutants.利用反式显性突变体探索分枝杆菌KatG蛋白的结构与功能。
Antimicrob Agents Chemother. 2003 Jan;47(1):188-95. doi: 10.1128/AAC.47.1.188-195.2003.

本文引用的文献

1
Pigments produced by Mycobacteria on exposure to isoniazid. 2.分枝杆菌在接触异烟肼时产生的色素。2.
Aust J Exp Biol Med Sci. 1962 Jun;40:197-9. doi: 10.1038/icb.1962.22.
2
Catalase and peroxidase in mycobacteria. Possible relationship to the mode of action of isoniazid.分枝杆菌中的过氧化氢酶和过氧化物酶。与异烟肼作用方式的可能关系。
Am Rev Respir Dis. 1960 Jan;81:68-78. doi: 10.1164/arrd.1960.81.1P1.68.
3
Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients.异烟肼与结核杆菌的研究。III. 来自接受异烟肼治疗患者的结核杆菌的分离、药敏性及过氧化氢酶检测
Am Rev Tuberc. 1954 Nov;70(5):852-72. doi: 10.1164/art.1954.70.5.852.
4
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.结核杆菌的异烟肼耐药性与过氧化氢酶活性;初步报告。
Am Rev Tuberc. 1954 Mar;69(3):471-2. doi: 10.1164/art.1954.69.3.471.
5
Tuberculosis: the return of an old enemy.结核病:宿敌卷土重来。
Crit Rev Microbiol. 1993;19(1):1-16. doi: 10.3109/10408419309113520.
6
Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations.用katG进行转化可恢复对一系列药物浓度耐药的结核分枝杆菌分离株的异烟肼敏感性。
Mol Microbiol. 1993 May;8(3):521-4. doi: 10.1111/j.1365-2958.1993.tb01596.x.
7
Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis.结核分枝杆菌对异烟肼敏感性所需的过氧化氢酶-过氧化物酶编码基因katG的特征分析。
J Bacteriol. 1993 Jul;175(13):4255-9. doi: 10.1128/jb.175.13.4255-4259.1993.
8
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.inhA,一种编码结核分枝杆菌中异烟肼和乙硫异烟胺靶点的基因。
Science. 1994 Jan 14;263(5144):227-30. doi: 10.1126/science.8284673.
9
The third epidemic--multidrug-resistant tuberculosis.第三次疫情——耐多药结核病。
Chest. 1994 Jan;105(1):45-8. doi: 10.1378/chest.105.1.45.
10
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.结核分枝杆菌中利福平耐药性突变的检测
Lancet. 1993 Mar 13;341(8846):647-50. doi: 10.1016/0140-6736(93)90417-f.